Grassley seeks Zyprexa documents
Senator Chuck Grassley, R-Iowa, is requesting that Lilly produce documents related to liability cases regarding Zyprexa (olanzapine). The Finance Committee Ranking Member sent an April 4 letter asking for documents that were made available to plaintiffs in various lawsuits alleging Lilly inadequately warned patients of risks associated with the atypical antipsychotic. The company recently announced it will pay up to $500 million to settle 18,000 claims, leaving 1,200 claims outstanding (1"The Pink Sheet" Jan. 8, 2007, p. 16)...
You may also be interested in...
Lilly will pay up to $500 million to settle the "vast majority" of claims alleging that the company failed to adequately warn patients of risks associated with the atypical antipsychotic Zyprexa (olanzapine), the firm announced Jan. 4
Ying Huang was named CEO as his predecessor came under investigation in China and as partner Janssen was getting closer to seeking US FDA approval for its lead CAR-T therapy.
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.